Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • chrt13sezzheaintkowtowing chrt13sezzheaintkowtowing Jan 23, 2009 9:58 AM Flag

    Issuing 2 billion shares at $16 can't be right

     

    For years now (2008 excepted), the company has been buying back copious amounts of its stock at $22.50 or higher. Back a few years it was much higher.

    This reduced materially the share count and added nicely to earnings per share. So how can it possibly be right to now be issuing something like 2 billion shares at $16 or so to fund half of a WYE acquisition?

    Two years ago, Pfizer spent over an 18-month period $9B of the net $13.5B in Consumer Products proceeds to buy back about 360 million shares at an average of about $25.

    Other years, it was regularly buying back maybe 200M shares per year.

    So it has to be a huge mistake to undo all of this good and to issue 2 billion shares at a price like $16. WYE with the loss of Effexor in three years just isn't that much of a prize to warrant that. Not with its high debt, its low 20% net profit margin and the highest tax level in the industry.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Too bad for you that what's right for shareholders is wrong for options losers like you!

    • It is a very dangerous move to buy Wyeth and it seems to be a political move to destroy the number one US drugmaker. Why kep all those high paid scientist forging the data of lapreports to give false research data. Why aren'T Pfizer
      HIRING IMMEDIATELY capable scientist and management. To hire the top notch scientist from Wyeth would cost around 10 million dollars. WHAT IS GOING ON IN THE
      USA ? IS THERE A COMMITED GROUP OF DEVILS TO DRIVE EVERY TOP NOTCH COMPANY OUT OF BUSINESS. ARE WE GOING TO BE THE NEXT BANK OF AMERICA

    • In the fullness of time, PFE hopes it will all work out. You can't blame them for buying back shares before the worst credit crunch market in the last 600 years. Sound familiar?

    • You simply pointed out the PFE stupidity. It will continue.

      >>.........For years now (2008 excepted), the company has been buying back copious amounts of its stock at $22.50 or higher. Back a few years it was much higher.

      This reduced materially the share count and added nicely to earnings per share. So how can it possibly be right to now be issuing something like 2 billion shares at $16 or so to fund half of a WYE acquisition?

      Two years ago, Pfizer spent over an 18-month period $9B of the net $13.5B in Consumer Products proceeds to buy back about 360 million shares at an average of about $25. <<<<<<<<<<<<<<,

    • why do you have a strong buy with all the negatives you said ??

 
PFE
33.46-0.38(-1.12%)May 6 4:00 PMEDT